{"id":27039,"date":"2021-08-02T08:50:07","date_gmt":"2021-08-02T05:50:07","guid":{"rendered":"https:\/\/aluksne.lv\/?p=27039"},"modified":"2021-08-02T08:52:07","modified_gmt":"2021-08-02T05:52:07","slug":"latvija-sakta-12-17-gadus-vecu-pusaudzu-vakcinacija-ar-spikevax-moderna","status":"publish","type":"post","link":"https:\/\/aluksne.lv\/index.php\/2021\/08\/02\/latvija-sakta-12-17-gadus-vecu-pusaudzu-vakcinacija-ar-spikevax-moderna\/","title":{"rendered":"Latvij\u0101 s\u0101kta 12-17 gadus vecu pusaud\u017eu vakcin\u0101cija ar Spikevax (Moderna)"},"content":{"rendered":"

Latvij\u0101 ir uzs\u0101kta 12-17 gadus vecu pusaud\u017eu vakcin\u0101cija ar Spikevax<\/em> (Moderna<\/em>) vakc\u012bn\u0101m. <\/strong>L\u012bdz \u0161im pusaud\u017eus no 12 gadu vecuma Latvij\u0101 vakcin\u0113ja tikai ar Pfizer<\/em>–BioNTech<\/em> ra\u017eoto vakc\u012bnu Comirnaty<\/em>.<\/p>\n

\u0160.g. 20. j\u016blij\u0101 Latvijas Z\u0101\u013cu valsts a\u0123ent\u016bra inform\u0113ja, ka Eiropas Z\u0101\u013cu a\u0123ent\u016bras (EZA) Cilv\u0113kiem paredz\u0113to z\u0101\u013cu komiteja (CHMP) ir ieteikusi apstiprin\u0101t Covid-19 vakc\u012bnas Spikevax<\/em> (Moderna<\/em>) lieto\u0161anu jaunie\u0161iem no 12 l\u012bdz 17 gadu vecumam. Iepriek\u0161 t\u0101 bija re\u0123istr\u0113ta lieto\u0161anai pieaugu\u0161ajiem no 18 gadu vecuma. Vakc\u012bnas lieto\u0161ana pusaud\u017eiem no 12 l\u012bdz 17 gadiem ir t\u0101da pati k\u0101 person\u0101m no 18 gadu vecuma.<\/p>\n

Vakc\u012bna tiek ievad\u012bta 2 injekciju veid\u0101 aug\u0161delma muskul\u012b ar \u010detru ned\u0113\u013cu interv\u0101lu. Vakc\u012bnas iedarb\u012bba tika p\u0113t\u012bta 3732 pusaud\u017eu vid\u016b vecum\u0101 no 12 l\u012bdz 17 gadiem. \u0160is p\u0113t\u012bjums tika veikts saska\u0146\u0101 ar \u201cSpikevax\u201d pediatrisk\u0101s izp\u0113tes pl\u0101nu (PIP), ko apstiprin\u0101jusi EZA Pediatrisk\u0101 komiteja. Bie\u017e\u0101k\u0101s nov\u0113rot\u0101s blakuspar\u0101d\u012bbas pusaud\u017eiem vecum\u0101 no 12 l\u012bdz 17 gadiem ir l\u012bdz\u012bgas t\u0101m, kas nov\u0113rotas ar\u012b pieaugu\u0161ajiem no 18 gadu vecuma. Atbildes uz bie\u017e\u0101k uzdotajiem jaut\u0101jumiem par Spikevax <\/em>(Moderna) <\/em>vakc\u012bn\u0101m – https:\/\/www.spkc.gov.lv\/lv\/jautajumi-par-moderna-razoto-vakcinu-spikevax<\/a><\/em><\/p>\n

Pusaud\u017eu pieteik\u0161an\u0101s iesp\u0113jas vakcin\u0101cijai – vietn\u0113 manavakcina.lv, pa t\u0101lruni 8989, pie sava \u0123imenes \u0101rsta vai \u0101rstniec\u012bbas iest\u0101d\u0113, vakcin\u0101cijas punktos tirdzniec\u012bbas centros (\u0161ajos punktos vakcin\u0101cija iesp\u0113jama ar\u012b br\u012bvaj\u0101 rind\u0101), iepriek\u0161 p\u0101rliecinoties, ka vakcin\u0101cijas iest\u0101d\u0113 ir pieejama Spikevax<\/em> (Moderna<\/em>) vakc\u012bnas.\u00a0<\/p>\n

Vakcin\u0101cijas k\u0101rt\u012bba 12-13 gadu veciem pusaud\u017eiem<\/strong><\/p>\n

Vakcin\u0101cijai personu var pieteikt<\/strong> vec\u0101ki vai citi likumiskie p\u0101rst\u0101vji \u0101rstniec\u012bbas iest\u0101d\u0113, pie \u0123imenes \u0101rsta vai pa t\u0101lruni 8989. Vakcin\u0101cijas laik\u0101 nepiecie\u0161ama<\/strong> m\u0101tes vai t\u0113va (vai cita likumisk\u0101 p\u0101rst\u0101vja) kl\u0101tb\u016btne, k\u0101 ar\u012b \u0161\u0101di dokumenti: likumiskajam p\u0101rst\u0101vim – pase vai personas apliec\u012bba, k\u0101 ar\u012b apliecino\u0161s dokuments par b\u0113rnu (ieraksts par b\u0113rnu pas\u0113 vai dzim\u0161anas apliec\u012bba, vai nepiecie\u0161am\u012bbas gad\u012bjum\u0101 notari\u0101li apstiprin\u0101ta pilnvara).<\/p>\n

Vakcin\u0101cijas k\u0101rt\u012bba pusaud\u017eiem no 14 gadiem<\/strong><\/p>\n

Atbilsto\u0161i Pacientu ties\u012bbu likuma 13. pantam nepilngad\u012bgiem pacientiem no 14 gadu vecuma \u0101rstniec\u012bba ir pie\u013caujama, ja sa\u0146emta vi\u0146u piekri\u0161ana, l\u012bdz ar to pusaud\u017ei no 14 gadu vecuma pa\u0161i var pie\u0146emt l\u0113mumu vakcin\u0113ties <\/strong>un nav nepiecie\u0161ama vec\u0101ku vai aizbild\u0146u at\u013cauja vakc\u012bnas sa\u0146em\u0161anai.<\/p>\n

Vakcin\u0101cijai pusaudzis pats var pierakst\u012bties<\/strong> vietn\u0113 www.manavakcina.lv<\/a><\/em>, <\/em>kur autentific\u0113\u0161an\u0101s notiek caur latvija.lv<\/em>. ja ir pieejama piln\u0101 internetbankas vai Smart-ID versija, vai zvanot pa t\u0101lruni 8989, k\u0101 vakcin\u0101cijas vietu nor\u0101dot k\u0101du no vakcin\u0101cijas centriem.<\/p>\n

Ierodoties uz vakcin\u0101ciju<\/strong>, pusaudzim j\u0101\u0146em l\u012bdzi personu apliecino\u0161s dokuments \u2013 pase vai<\/u> ID; ja jaunietim nav pases vai ID, tad j\u0101dodas uz vakcin\u0101ciju ar likumisko p\u0101rst\u0101vi.<\/p>\n

L\u012bdz 31. j\u016blijam vienu vakc\u012bnas devu ir sa\u0146\u0113mu\u0161i 16 % pusaud\u017eu vecum\u0101 no 12 l\u012bdz 15 gadiem un 32 % pusaud\u017eu vecum\u0101 no 16 l\u012bdz 17 gadiem.<\/p>\n

Ned\u0113\u013cas nogal\u0113 b\u016bs pieejams izbraukuma vakcin\u0101cijas pakalpojums vair\u0101k\u0101s cilv\u0113ku pulc\u0113\u0161an\u0101s viet\u0101s ar Pfizer<\/em>–BioNTech<\/em> ra\u017eoto vakc\u012bnu Comirnaty<\/em>, darbosies liela m\u0113roga vakcin\u0101cijas centri un vakcin\u0101cijas punktu tirdzniec\u012bbas centros, to darb\u012bbas dienu grafiks, k\u0101 ar\u012b vakc\u012bnu saraksts, kas tajos pieejams, atrodams \u0161eit<\/a><\/strong>.\u00a0 \u0160\u012b tabula tiek atjaunota reizi ned\u0113\u013c\u0101 pirmdien\u0101s l\u012bdz plkst.10:00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Latvij\u0101 ir uzs\u0101kta 12-17 gadus vecu pusaud\u017eu vakcin\u0101cija ar Spikevax (Moderna) vakc\u012bn\u0101m. L\u012bdz \u0161im pusaud\u017eus no 12 gadu vecuma Latvij\u0101 vakcin\u0113ja tikai ar Pfizer–BioNTech ra\u017eoto vakc\u012bnu Comirnaty. \u0160.g. 20. j\u016blij\u0101 Latvijas Z\u0101\u013cu valsts a\u0123ent\u016bra inform\u0113ja, ka Eiropas Z\u0101\u013cu a\u0123ent\u016bras (EZA)…
Las\u012bt visu<\/a><\/p>\n","protected":false},"author":1,"featured_media":23415,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[9],"tags":[],"class_list":["post-27039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noderiga-informacija"],"_links":{"self":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/27039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/comments?post=27039"}],"version-history":[{"count":0,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/27039\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media\/23415"}],"wp:attachment":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media?parent=27039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/categories?post=27039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/tags?post=27039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}